Your 25-second video preview has ended.

to continue watching, please Log In or Register:

Log in / Register

Examining the Long-Term Treatment Burden of DME

  Channels: Retina | Posted 5/18/2017

Charles C. Wykoff, MD, PhD, speaks with Richard S. Kaiser, MD, regarding long-term treatment burdens for patients with diabetic macular edema (DME). Dr. Wykoff compares data from clinical trials that assess the need for ongoing anti-VEGF therapy injections in patients with DME after 3 years of treatment. The two physicians also discuss details of the ENDURANCE Trial—a 12-month extension study to the VISTA DME trial.

Anti-VEGF • Diabetic macular edema, DME

12 / 60 Series: Retina Today Journal Club

More Videos in this Series